Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute (PRI), are working in collaboration within the ‘Intestinal Microbiome-based Medicines European Task Group (IMM-ETG)’ to propose a harmonised, pan-European, regulatory […]
Dr Lindsay Hall of the Quadram Institute talks to us about the preterm infant gut microbiota and its modulation.
This 5th Pharmabiotics Conference Edition, hosted by the Pharmabiotic Research Institute, took place Mid-March in Paris and peaked as the most successful to date, with over 190 delegates attending over the 2-day event. As in […]
This month’s 5-minute microbiome science roundup includes some important papers published this month related to both health and disease. The two colorectal cancer microbiome-related papers published in Nature are a sign that the field is beginning […]
Why Phages, and Why Now? Many modern diseases have been linked to alterations in the microbiome and changing it back could be the key to restoring health. Bacteriophages (phages) are viruses that kill bacteria with […]
This interview was originally published on the Biofortis Mérieux NutriSciences’ Blog. Pr Nicola Segata (Centre for Integrative Biology (CIBIO), University of Trento, Italy) received a €10,000 award from Institut Mérieux, on March 13th at Pharmabiotics 2019 to support his research […]
Three studies published in the journal Gut over the past 5 years describe how the gut microbiome of African infants is affected not only by dietary iron but also by the combination of iron with antibiotics […]
Kristina Campbell talks to Aoife Brennan to find out how Synlogic is pioneering the development of engineered probiotics to deliver specific functions in the human body to compliment for deficiencies brought about by disease.
Following Biofortis first paper The human microbiome: a global overview of clinical trials activity, this article compares the emergence of the human microbiome field with the rise of human genomics through a review on how […]
March saw the publication of many excellent scientific publications related to different aspects of the microbiome. Here’s a 5-minute roundup of 5 recent papers worth knowing about. A Weaning Reaction to Microbiota Is Required for […]
While the microbiome space is often compared to the traditional pharmaceutical and biotechnology industries, the scientific, regulatory, and marketing strategies for microbiome products and platforms often differ from those centered on a single small molecule or large […]